Samsung Biologics: Regulators Crack Down On Its Accounting
After the market close today, the Korean regulators (Financial Services Commission) made a major negative announcement on Samsung Biologics Co.,...
467 Views
Korea Stock Market Monthly Recap #26 (June 2018)
"Sell in May and Go Away" continued its trend in the Korea Stock Market in June. Since end of April, KOSPI is down 7.5% in terms of Won and it is...
177 Views
Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option. Link of this...
259 Views
The Week That Was In North Asia@Smartkarma: Won Depreciation, Mercari, & 11st Spin-Off & Investment
It has been an eventful week in North Asia. The biggest story was the hugely successful IPO of Mercari in Japan. In Korea, SK Telecom continued its...
131 Views
Why Is the Moon Administration So Anti-Samsung?
It has been more than a year since Moon Jae-In has become the President of South Korea. Since this period, it has been becoming more apparent that...
133 Views